差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

交易 Teva Pharma Ind Adr Rep 1 - TEVA CFD

8.78
0.23%
0.07
低: 8.76
高: 8.9
Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.07
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.024874%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
0.002651%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

Teva Pharmaceutical Industries Ltd ESG Risk Ratings

High Medium Low Negligible

“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。

關鍵數據
前收盤價* 8.8
開盤價* 8.9
1 年變化* 1.83%
日範圍* 8.76 - 8.9
52 周範圍 6.78-11.45
平均交易量(10 天) 11.54M
平均交易量(3 個月) 192.94M
市值 9.87B
市盈率 -100.00K
流通股 1.11B
收入 14.93B
EPS -2.12
股息(收益率 %) N/A
貝塔 1.20
下一個財報發布日期 May 1, 2023

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開
Mar 30, 2023 8.78 -0.05 -0.57% 8.83 8.93 8.75
Mar 29, 2023 8.80 0.13 1.50% 8.67 8.87 8.67
Mar 28, 2023 8.73 0.06 0.69% 8.67 8.81 8.65
Mar 27, 2023 8.69 0.12 1.40% 8.57 8.73 8.51
Mar 24, 2023 8.40 -0.03 -0.36% 8.43 8.50 8.25
Mar 23, 2023 8.50 -0.23 -2.63% 8.73 8.79 8.37
Mar 22, 2023 8.69 -0.19 -2.14% 8.88 8.97 8.69
Mar 21, 2023 8.75 0.17 1.98% 8.58 8.95 8.57
Mar 20, 2023 8.50 0.18 2.16% 8.32 8.60 8.24
Mar 17, 2023 8.33 0.00 0.00% 8.33 8.42 8.27
Mar 16, 2023 8.47 -0.04 -0.47% 8.51 8.54 8.33
Mar 15, 2023 8.63 -0.06 -0.69% 8.69 8.69 8.47
Mar 14, 2023 8.87 -0.11 -1.22% 8.98 9.08 8.80
Mar 13, 2023 8.90 -0.11 -1.22% 9.01 9.07 8.87
Mar 10, 2023 9.09 -0.12 -1.30% 9.21 9.31 9.05
Mar 9, 2023 9.27 -0.32 -3.34% 9.59 9.64 9.27
Mar 8, 2023 9.47 -0.01 -0.11% 9.48 9.65 9.30
Mar 7, 2023 9.40 -0.31 -3.19% 9.71 9.76 9.32
Mar 6, 2023 9.77 -0.24 -2.40% 10.01 10.10 9.77
Mar 3, 2023 9.94 0.03 0.30% 9.91 10.03 9.89

Teva Pharma Ind Adr Rep 1 Events

时间(协调世界时) (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2022 2021 2020 2019 2018
總收入 14925 15878 16659 16887 18854
收入 14925 15878 16659 16887 18854
收入成本,共計 7487 8014 8870 9351 10558
毛利 7438 7864 7789 7536 8296
總營業費用 17024 14162 20231 17330 20537
銷售/一般/行政費用,總計 3445 3402 3519 3667 4052
研究與開發 838 967 997 1010 1213
異常費用(收入) 5239 1721 6739 3191 4838
Other Operating Expenses, Total 15 -41 -20 -28 -286
營業收入 -2099 1716 -3572 -443 -1683
利息收入(費用),非經營淨值 -904 -988 -833 -825 -894
其他,淨值 -62 -70 -1 3 -19
稅前淨收入 -3065 658 -4406 -1265 -2596
稅後淨收入 -2427 447 -4238 -987 -2304
少數股東權益 53 -39 109 2 322
Equity In Affiliates 21 9 138 -13 -71
未計算非常項目前的淨收益 -2353 417 -3991 -998 -2053
非常規項目總計 0 0 -97
淨收入 -2353 417 -3991 -998 -2150
Total Adjustments to Net Income 1 -1 -249
普通股股東可獲收益 (不含非經常性項目) -2353 417 -3990 -999 -2302
普通股股東可獲收益 (含非經常性項目) -2353 417 -3990 -999 -2399
攤薄調整
攤薄淨收入 -2353 417 -3990 -999 -2399
攤薄後加權平均股 1110 1107 1095 1091 1021
扣除特別項目的每股攤薄盈利 -2.11982 0.37669 -3.64384 -0.91567 -2.25465
Dividends per Share - Common Stock Primary Issue 0
每股正常攤薄盈利 0.94806 1.43282 0.35648 0.98547 0.82537
Depreciation / Amortization 99 126 139 162
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
總收入 3884 3595 3786 3661 4100
收入 3884 3595 3786 3661 4100
收入成本,共計 1784 1885 1958 1859 1975
毛利 2100 1710 1828 1802 2125
總營業費用 4739 3176 4735 4374 4022
銷售/一般/行政費用,總計 837 777 849 819 858
研究與開發 210 175 228 225 249
Depreciation / Amortization 20 21 22 23
異常費用(收入) 1854 321 1683 1502 893
Other Operating Expenses, Total 54 -2 -4 -53 24
營業收入 -855 419 -949 -713 78
利息收入(費用),非經營淨值 -237 -230 -225 -238 -170
其他,淨值 -9 -23 14 -20 -83
稅前淨收入 -1101 166 -1160 -971 -175
稅後淨收入 -1255 59 -260 -973 -151
少數股東權益 32 -3 27 -3 -7
Equity In Affiliates 1 -1 0 21 0
未計算非常項目前的淨收益 -1222 55 -233 -955 -158
淨收入 -1222 55 -233 -955 -158
Total Adjustments to Net Income 1 1 1 -1
普通股股東可獲收益 (不含非經常性項目) -1221 56 -232 -955 -159
普通股股東可獲收益 (含非經常性項目) -1221 56 -232 -955 -159
攤薄淨收入 -1221 56 -232 -955 -159
攤薄後加權平均股 1113 1119 1110 1107 1102
扣除特別項目的每股攤薄盈利 -1.09704 0.05004 -0.20901 -0.86269 -0.14428
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常攤薄盈利 -0.01429 0.23651 0.77653 0.01924 0.38244
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 12573 13005 13464 13794 15382
現金和短期投資 2165 2177 1975 1784 977
現金等價物 2165 2177 1975 1782 963
短期投資 2 14
應收賬款總額,淨額 4529 4581 5676 5822 7128
Accounts Receivable - Trade, Net 4529 4581 5676 5822 7128
Total Inventory 3818 4403 4422 4731 4924
Prepaid Expenses 1075 945 870 899 1100
Other Current Assets, Total 986 899 521 558 1253
Total Assets 47666 50640 57470 60683 70615
Property/Plant/Equipment, Total - Net 6477 6855 6950 6868 7673
Property/Plant/Equipment, Total - Gross 11718 11947 11864 11796 12178
Accumulated Depreciation, Total -5241 -5092 -4914 -4928 -4505
Goodwill, Net 20040 20624 24846 24917 28414
Intangibles, Net 7466 8923 11232 14005 17640
Other Long Term Assets, Total 1110 1233 978 1038 1423
Total Current Liabilities 11027 13164 13674 14322 17921
Accounts Payable 1686 1756 1718 1853 2069
Accrued Expenses 2880 2581 2680 2738 3563
Notes Payable/Short Term Debt 23 514 514 516 766
Current Port. of LT Debt/Capital Leases 1403 2674 1831 1700 2880
Other Current Liabilities, Total 5035 5639 6931 7515 8643
Total Liabilities 37388 40614 43498 45976 53256
Total Long Term Debt 21617 22731 24562 26691 28827
Long Term Debt 21617 22731 24562 26691 28827
Deferred Income Tax 784 964 1096 2140 3277
Minority Interest 966 1035 1091 1087 1386
Other Liabilities, Total 2994 2720 3075 1736 1845
Total Equity 10278 10026 13972 14707 17359
Redeemable Preferred Stock 0 3631
Common Stock 57 57 56 56 54
Additional Paid-In Capital 27561 27443 27312 27210 23479
Retained Earnings (Accumulated Deficit) -10529 -10946 -6956 -5958 -3803
Treasury Stock - Common -4128 -4128 -4128 -4142 -4149
Unrealized Gain (Loss) 0 0 0 1 -4
Other Equity, Total -2683 -2400 -2312 -2460 -1849
Total Liabilities & Shareholders’ Equity 47666 50640 57470 60683 70615
Total Common Shares Outstanding 1103.33 1096.51 1092.19 1089.39 1016.88
Total Preferred Shares Outstanding 0 0 0 3.7
Long Term Investments 61 83
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 12451 12573 12154 12822 12401
現金和短期投資 2175 2165 2045 2436 1743
現金等價物 2175 2165 2045 2436 1743
應收賬款總額,淨額 4253 4529 4046 4488 4572
Accounts Receivable - Trade, Net 4253 4529 4046 4488 4572
Total Inventory 4012 3818 4167 4362 4406
Prepaid Expenses 1064 1075 1066 1022 942
Other Current Assets, Total 947 986 830 514 738
Total Assets 47059 47666 47851 49195 49004
Property/Plant/Equipment, Total - Net 6396 6477 6547 6658 6641
Goodwill, Net 19986 20040 20179 20421 20302
Intangibles, Net 7116 7466 7832 8120 8445
Other Long Term Assets, Total 1110 1110 1139 1174 1215
Total Current Liabilities 11613 11027 11825 12691 12089
Accounts Payable 1750 1686 1514 1551 1692
Accrued Expenses 3078 2771 2590 2318 2377
Notes Payable/Short Term Debt 23 23 323 23 23
Current Port. of LT Debt/Capital Leases 2054 1403 2386 3507 2674
Other Current Liabilities, Total 4708 5144 5012 5292 5323
Total Liabilities 37715 37388 37384 38871 39004
Total Long Term Debt 20840 21617 21037 21602 22288
Long Term Debt 20840 21617 21037 21602 22288
Deferred Income Tax 666 784 910 932 991
Minority Interest 916 966 984 987 975
Other Liabilities, Total 3680 2994 2628 2659 2661
Total Equity 9344 10278 10467 10324 10000
Common Stock 57 57 57 57 57
Additional Paid-In Capital 27587 27561 27529 27503 27474
Retained Earnings (Accumulated Deficit) -11484 -10529 -10370 -10662 -10869
Treasury Stock - Common -4128 -4128 -4128 -4128 -4128
Other Equity, Total -2688 -2683 -2621 -2446 -2534
Total Liabilities & Shareholders’ Equity 47059 47666 47851 49195 49004
Total Common Shares Outstanding 1110.35 1103.33 1103.01 1102.89 1102.35
Total Preferred Shares Outstanding 0
Unrealized Gain (Loss) 0
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 456 -4099 -1000 -2472 -16449
經營活動産生的現金 798 1216 748 2446 2225
經營活動産生的現金 1330 1557 1722 1842 2112
Deferred Taxes -120 -696 -985 -837 -2331
非現金物品 833 6642 1907 5736 20538
Cash Taxes Paid 495 709 552 420 106
已付現金利息 913 846 840 815 795
營運資金的變化 -1701 -2188 -896 -1823 -1645
投資活動産生的現金 1523 863 1355 1866 3446
資本支出 -562 -578 -525 -651 -874
其他投資現金流量項目,總計 2085 1441 1880 2517 4320
融資活動産生的現金 -2172 -1885 -1926 -3351 -5750
融資現金流項目 -6 -5 -11 -57 -112
Total Cash Dividends Paid 0 0 -52 -22 -1161
股票的發行(報廢),淨額 0 0
債務的發行(退還),淨額 -2166 -1880 -1863 -3272 -4477
外彙效應 -128 8 16 -142 54
現金淨變化 21 202 193 819 -25
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -952 456 608 306 84
Cash From Operating Activities -49 798 342 -187 -405
Cash From Operating Activities 323 1330 1010 681 376
Deferred Taxes -175 -120 13 5 -11
Non-Cash Items 196 833 592 500 222
Changes in Working Capital 559 -1701 -1881 -1679 -1076
Cash From Investing Activities 161 1523 1277 989 508
Capital Expenditures -157 -562 -409 -263 -150
Other Investing Cash Flow Items, Total 318 2085 1686 1252 658
Cash From Financing Activities 2 -2172 -1671 -494 -493
Financing Cash Flow Items 2 -6 -5 -3 -2
Issuance (Retirement) of Debt, Net 0 -2166 -1666 -491 -491
Foreign Exchange Effects -62 -128 -80 -49 -44
Net Change in Cash 52 21 -132 259 -434
Total Cash Dividends Paid 0
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Capital Research Global Investors Investment Advisor 10.3344 114793989 -2396339 2022-12-31 LOW
Capital World Investors Investment Advisor 4.5521 50563987 11234222 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.7581 30636834 -963743 2022-12-31 LOW
Menora Mivtachim Insurance Ltd. Insurance Company 2.0944 23264560 -43000 2022-12-31 LOW
Phoenix Holdings Ltd Holding Company 1.9948 22158551 1327471 2022-12-31 MED
Migdal Insurance and Financial Holdings Ltd Insurance Company 1.9442 21596560 216360 2022-12-31 MED
Clal Insurance Enterprises Holdings Ltd. Investment Advisor 1.6591 18429666 -977100 2022-12-31 LOW
Abrams Capital, L.L.C. Hedge Fund 1.4344 15932865 -7966431 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3615 15122945 221012 2022-12-31 LOW
Harel Insurance Investments and Financial Services Ltd Investment Advisor 1.361 15118229 985502 2022-12-31 LOW
EXOR Investments (UK) LLP Investment Advisor 1.3511 15008389 3486202 2022-12-31 LOW
Capital International Investors Investment Advisor 0.9612 10677340 2109 2022-12-31 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.8718 9683798 1534941 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.7409 8229628 245827 2022-12-31 HIGH
Camber Capital Management LP Hedge Fund 0.6302 7000000 -500000 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5893 6545401 -87713 2022-12-31 LOW
Beck, Mack & Oliver LLC Investment Advisor 0.573 6364333 -1172652 2022-12-31 LOW
BSN Capital Partners Ltd Investment Advisor 0.5402 6000000 6000000 2022-12-31 HIGH
Ion Asset Management Israel Ltd Hedge Fund 0.4679 5197393 5197393 2022-12-31 HIGH
Miller Value Partners, LLC Investment Advisor 0.4634 5147027 -4107848 2022-12-31 MED

為什麼選擇Capital.com?我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Pharmaceuticals (NEC)

5 Bazel St
P O B 3190
PETAH TIKVA
49131
IL

收入報表

  • Annual
  • Quarterly

人們也觀看

BTC/USD

27,854.90 Price
-1.170% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

US100

12,965.50 Price
-0.020% 1D Chg, %
多頭倉位隔夜費用 -0.0249%
空頭倉位隔夜費用 0.0027%
隔夜費時間 21:00 (UTC)
價差 1.8

Oil - Crude

74.44 Price
+0.070% 1D Chg, %
多頭倉位隔夜費用 -0.0170%
空頭倉位隔夜費用 -0.0049%
隔夜費時間 21:00 (UTC)
價差 0.03

Gold

1,979.93 Price
-0.030% 1D Chg, %
多頭倉位隔夜費用 -0.0180%
空頭倉位隔夜費用 0.0098%
隔夜費時間 21:00 (UTC)
價差 0.30

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易